Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 538670, 5 pages
http://dx.doi.org/10.1155/2015/538670
Research Article

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

1Laboratório de Fisiopatologia Experimental, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806000 Criciúma, SC, Brazil
2Programa de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, 88704900 Tubarão, SC, Brazil
3Departamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 14049900 Ribeirão Preto, SP, Brazil

Received 16 April 2015; Revised 12 May 2015; Accepted 13 May 2015

Academic Editor: Jan G. C. van Amsterdam

Copyright © 2015 Francieli Vuolo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Laughter, J. A. Istvan, S. J. Tofte, and J. M. Hanifin, “The prevalence of atopic dermatitis in Oregon schoolchildren,” Journal of the American Academy of Dermatology, vol. 43, no. 4, pp. 649–655, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ker and T. V. Hartert, “The atopic march: what's the evidence?” Annals of Allergy, Asthma and Immunology, vol. 103, no. 4, pp. 282–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. T. Holgate, “Pathogenesis of asthma,” Clinical and Experimental Allergy, vol. 38, no. 6, pp. 872–897, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Cunha, E. A. Carlini, A. E. Pereira et al., “Chronic administration of cannabidiol to healthy volunteers and epileptic patients,” Pharmacology, vol. 21, no. 3, pp. 175–185, 1980. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Burtein, “Cannabidiol (CBD) and its analogs: a review of their effects on inflammation,” Bioorganic & Medicinal Chemistry, vol. 1, pp. 1377–1385, 2015. View at Google Scholar
  6. R. G. Pertwee, “The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin,” British Journal of Pharmacology, vol. 153, no. 2, pp. 199–215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. F. Chung, “New treatments for severe treatment-resistant asthma: targeting the right patient,” The Lancet Respiratory Medicine, vol. 1, no. 8, pp. 639–652, 2013. View at Publisher · View at Google Scholar
  8. A. W. Zuardi, J. A. S. Crippa, J. E. C. Hallak, F. A. Moreira, and F. S. Guimarães, “Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug,” Brazilian Journal of Medical and Biological Research, vol. 39, no. 4, pp. 421–429, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. M. Bergamaschi, R. H. C. Queiroz, A. W. Zuardi, and J. A. S. Crippa, “Safety and side effects of cannabidiol, a Cannabis sativa constituent,” Current Drug Safety, vol. 6, no. 4, pp. 237–249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. W. Zuardi, “Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action,” Revista Brasileira de Psiquiatria, vol. 30, no. 3, pp. 271–280, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Mechoulam, L. A. Parker, and R. Gallily, “Cannabidiol: an overview of some pharmacological aspects,” Journal of Clinical Pharmacology, vol. 42, no. 11, pp. 11S–19S, 2002. View at Google Scholar · View at Scopus
  12. A. Ribeiro, V. Ferraz-De-Paula, M. L. Pinheiro et al., “Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A2A receptor,” European Journal of Pharmacology, vol. 678, no. 1–3, pp. 78–85, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. T. Nials and S. Uddin, “Mouse models of allergic asthma: acute and chronic allergen challenge,” Disease Models and Mechanisms, vol. 1, no. 4-5, pp. 213–220, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Humbert, S. R. Durham, S. Ying et al., “IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against 'intrinsic' asthma being a distinct immunopathologic entity,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 5, pp. 1497–1504, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. T. C. Kotsimbos, P. Ernst, and Q. A. Hamid, “Interleukin-13 and interleukin-4 are coexpressed in atopic asthma,” Proceedings of the Association of American Physicians, vol. 108, no. 5, pp. 368–373, 1996. View at Google Scholar · View at Scopus
  16. S. Ying, M. Humbert, J. Barkans et al., “Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics,” The Journal of Immunology, vol. 158, no. 7, pp. 3539–3544, 1997. View at Google Scholar · View at Scopus
  17. T. G. Uhm, B. S. Kim, and Y. S. Chung II, “Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma,” Allergy, Asthma and Immunology Research, vol. 4, no. 2, pp. 68–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. F. A. DiGiovanni, R. Ellis, J. Wattie, J. A. Hirota, D. S. Southam, and M. D. Inman, “Concurrent dual allergen exposure and its effects on airway hyperresponsiveness, inflammation and remodeling in mice,” DMM Disease Models and Mechanisms, vol. 2, no. 5-6, pp. 275–282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Wenzel, D. Wilbraham, R. Fuller, E. B. Getz, and M. Longphre, “Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies,” The Lancet, vol. 370, no. 9596, pp. 1422–1431, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. van Snick, “Interleukin-6: an overview,” Annual Review of Immunology, vol. 8, pp. 253–278, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. S. C. Erzurum, “Inhibition of tumor necrosis factor α for refractory asthma,” The New England Journal of Medicine, vol. 354, no. 7, pp. 754–758, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Flood-Page, C. Swenson, I. Faiferman et al., “A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma,” The American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 11, pp. 1062–1071, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Corren, R. F. Lemanske Jr., N. A. Hanania et al., “Lebrikizumab treatment in adults with asthma,” The New England Journal of Medicine, vol. 365, no. 12, pp. 1088–1098, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Parker, C. K. Oh, C. LaForce et al., “Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma,” BMC Pulmonary Medicine, vol. 11, article 14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. V. L. Hegde, U. P. Singh, P. S. Nagarkatti, and M. Nagarkatti, “Critical role of mast cells and peroxisome proliferator-activated receptor γ in the induction of myeloid-derived suppressor cells by marijuana cannabidiol in vivo,” The Journal of Immunology, 2015. View at Publisher · View at Google Scholar
  26. B. L. F. Kaplan, A. E. B. Springs, and N. E. Kaminski, “The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT),” Biochemical Pharmacology, vol. 76, no. 6, pp. 726–737, 2008. View at Publisher · View at Google Scholar · View at Scopus